More than 90% of therapeutic candidates fail to make it past phase III clinical trials, mainly due to the lack of adequate, advanced cell models to provide in-depth predictive insights that can translate into positive clinical outcomes. Comprehensive, 3D cell biological and stem cell-based models such as organoids and spheroids, more accurately mirror the diverse cellular ecosystem of complex tissues and provide invaluable insights into disease mechanisms, progression, and response to treatment.
This half-day event from Sartorius features two complementary, automated platforms that are revolutionizing the way advanced cell models are being created by introducing real-time live-cell analysis alongside automated cell selection and retrieval into drug discovery workflows.
Learn more about: